Company Filing History:
Years Active: 1994
Title: Margot S. Kruskall: Innovator in Erythropoietin Detection
Introduction
Margot S. Kruskall is a notable inventor based in Dover, Massachusetts. She has made significant contributions to the field of medical diagnostics, particularly in the detection of erythropoietin use. Her innovative work has implications for both therapeutic applications and the integrity of competitive sports.
Latest Patents
Margot S. Kruskall holds one patent titled "In-vitro method for determining a surreptitious use of exogenous erythropoietin." This invention describes an in-vitro blood assay method that determines the past and/or present use of exogenous erythropoietin by a living subject. The method effectively detects, identifies, and assesses the consequences of using exogenous erythropoietin to increase red blood cell production. It provides a reliable methodology to differentiate between unauthorized and authorized therapeutic uses of erythropoietin.
Career Highlights
Margot is affiliated with Beth Israel Hospital Association, where she applies her expertise in medical research and diagnostics. Her work has been instrumental in advancing the understanding of erythropoietin's role in both health and sports.
Collaborations
Some of her notable coworkers include Carlo Brugnara and Mark A. Goldberg, who have collaborated with her on various research projects.
Conclusion
Margot S. Kruskall's contributions to the field of erythropoietin detection highlight her innovative spirit and dedication to medical science. Her work not only enhances diagnostic capabilities but also promotes ethical standards in sports and medicine.